These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15329855)

  • 1. Metabolism of 1-(3-[3-(4-cyanobenzyl)-3H-imidazol-4-yl]-propyl)-3-(6-methoxypyridin-3-yl)-1-(2-trifluoromethylbenzyl)thiourea (YH3945), a novel anti-cancer drug, in rats using the 14C-labeled compound.
    Lee J; La S; Ahn BR; Jeong TC; Kim DH
    Rapid Commun Mass Spectrom; 2004; 18(17):1901-10. PubMed ID: 15329855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and excretion of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo[3,2-d]-pyrimidin-4-one (SK3530) in rats.
    Lee J; Yoo HH; Rhim KJ; Sohn DR; Kim DH
    Rapid Commun Mass Spectrom; 2007; 21(7):1139-49. PubMed ID: 17318927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and metabolism of 2-(2''(1'',3''-dioxolan-2-yl)-2- methyl-4-(2'-oxopyrrolidin-1-Yl)-6-nitro-2h-1-benzopyran (SKP-450) in rats.
    Baek M; Chung HS; Kim Y; Kim DH
    Drug Metab Dispos; 1999 Apr; 27(4):510-6. PubMed ID: 10101146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
    Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
    Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of urinary metabolites of ecabapide in rat.
    Fujimaki Y; Hosokami T; Ono K
    Xenobiotica; 1995 May; 25(5):501-10. PubMed ID: 7571723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
    Prakash C; Cui D; Potchoiba MJ; Butler T
    Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism, distribution, and excretion of a next generation selective estrogen receptor modulator, lasofoxifene, in rats and monkeys.
    Prakash C; Johnson KA; Schroeder CM; Potchoiba MJ
    Drug Metab Dispos; 2008 Sep; 36(9):1753-69. PubMed ID: 18515329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of the novel inotropic agent toborinone (OPC-18790) in rats and dogs. Evidence for the formation of novel glutathione and two cysteine conjugates.
    Kitani M; Miyamoto G; Nagasawa M; Yamada T; Matsubara J; Uchida M; Odomi M
    Drug Metab Dispos; 1997 Jun; 25(6):663-74. PubMed ID: 9193867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy.
    Colizza K; Awad M; Kamel A
    Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 3-chloro-4-fluoroaniline in rat using [14C]-radiolabelling, 19F-NMR spectroscopy, HPLC-MS/MS, HPLC-ICPMS and HPLC-NMR.
    Duckett CJ; Lindon JC; Walker H; Abou-Shakra F; Wilson ID; Nicholson JK
    Xenobiotica; 2006 Jan; 36(1):59-77. PubMed ID: 16507513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excretion and metabolism of the antihypertensive agent, RWJ-26240 (McN-5691) in dogs.
    Wu WN; Masucci JA; Caldwell GW; Carson JR
    Drug Metab Dispos; 1998 Feb; 26(2):115-25. PubMed ID: 9456297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of major biliary and urinary metabolites of ecabapide in rats.
    Nakaoka M; Tsumura M; Ichikawa E; Suzuki W; Hakusui H; Nakazawa T
    Xenobiotica; 1996 Sep; 26(9):983-94. PubMed ID: 8893045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of metabolites of tanshinone IIA in rats by liquid chromatography/tandem mass spectrometry.
    Li P; Wang GJ; Li J; Hao HP; Zheng CN
    J Mass Spectrom; 2006 May; 41(5):670-84. PubMed ID: 16598708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of a 14C/3H-labeled GABAA receptor partial agonist in rat, dog and human liver microsomes: evaluation of a dual-radiolabel strategy.
    Shaffer CL; Langer CS
    J Pharm Biomed Anal; 2007 Mar; 43(4):1195-205. PubMed ID: 17150324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolites of R, S-1-(2-methoxyphenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazin in rat plasma].
    Li L; Zhou X; Yuan M; Zhou H; Wang DP
    Yao Xue Xue Bao; 2006 Jan; 41(1):80-4. PubMed ID: 16683533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.